Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Soon Lee

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Biochimica Et Biophysica Acta|February 5, 2016
Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeuticsDanuta S Kalinowski, Christian Stefani, Shinya Toyokuni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosisKrishan K Rasiah, James G Kench, Margaret Gardiner-Garden, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2013
Smg1 haploinsufficiency predisposes to tumor formation and inflammationTara L Roberts, Uda Ho, John Luff, et al.
International Journal of Cancer|August 14, 2009
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusNiamh C Murphy, Andrew V Biankin, Ewan K A Millar, et al.
Oncogene|September 5, 2003
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancerSusan M Henshall, Daniel E H Afar, Krishan K Rasiah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2017
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancerJia-Min B Pang, Peter Savas, Andrew P Fellowes, et al.
Gastroenterology|April 21, 2009
Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancerAndrew V Biankin, James G Kench, Emily K Colvin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2026
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohortsAdel T Aref, Mohashin Pathan, Rosemary Habib, et al.
Pathology|December 23, 2021
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian settingRichard A Scolyer, Victoria Atkinson, David E Gyorki, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Biochimica Et Biophysica Acta|February 5, 2016
Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeuticsDanuta S Kalinowski, Christian Stefani, Shinya Toyokuni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosisKrishan K Rasiah, James G Kench, Margaret Gardiner-Garden, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2013
Smg1 haploinsufficiency predisposes to tumor formation and inflammationTara L Roberts, Uda Ho, John Luff, et al.
International Journal of Cancer|August 14, 2009
Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusNiamh C Murphy, Andrew V Biankin, Ewan K A Millar, et al.
Oncogene|September 5, 2003
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancerSusan M Henshall, Daniel E H Afar, Krishan K Rasiah, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2017
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancerJia-Min B Pang, Peter Savas, Andrew P Fellowes, et al.
Gastroenterology|April 21, 2009
Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancerAndrew V Biankin, James G Kench, Emily K Colvin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2026
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohortsAdel T Aref, Mohashin Pathan, Rosemary Habib, et al.
Pathology|December 23, 2021
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian settingRichard A Scolyer, Victoria Atkinson, David E Gyorki, et al.
Pageof 9